Ultragenyx Pharmaceutical Inc. buy Guggenheim
Start price
20.06.25
/
50%
€32.00
Target price
20.06.26
€55.59
Performance (%)
-36.88%
Price
05.02.26
€20.20
Summary
This prediction is currently active. Massive losses of -36.88% have been the result for the BUY prediction by Guggenheim. This prediction currently runs until 20.06.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 2.970% | 2.970% |
| iShares Core DAX® | -0.197% | -1.724% |
| iShares Nasdaq 100 | -3.612% | -3.768% |
| iShares Nikkei 225® | 1.176% | 2.165% |
| iShares S&P 500 | -0.825% | -1.916% |
Comments by Guggenheim for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $64.00 price target on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Guggenheim for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€20.00
05.01.26
05.01.26
€44.47
05.01.27
05.01.27
1.00%
05.02.26
05.02.26
